The effect of 1-day multidisciplinary clinic on breast cancer treatment

Akhtar, Zohaib; Stearns, Vered; Cartwright, Paul; Blackford, Amanda L.; Prasath, Vishnu; Klein, Catherine; Jelovac, Danijela; Asrari, F.; Habibi, Mehran

doi:10.1007/s10549-020-05721-3

Cited by 9 publications

(28 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In their study, median time to NAC was 22 days (similar to our median of 20.5 days) and median time to surgery was 31 days (our median was 27 days). 27 TTT was similar between the aforementioned study and our study, despite the fact that these analyses assessed different models of healthcare—the American and Canadian healthcare systems.…”

Section: Discussionsupporting

confidence: 82%

Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

2021

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 82%

Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

2021

View full text Add to dashboard Cite

“…The studies included were published between 2006 and 2021 [5,8,[16][17][18][19][20][21][22][23][24][25][26][27].…”

Section: Resultsmentioning

confidence: 99%

“…Regarding the study design: 6 (43%) were historical cohort studies [5,8,21,24,25,27], 5 (36%) were before and after studies [16,19,20,22,23], 1 (7%) was a cohort study [26], 1 (7%) was a retrospective interventional cohort study [17] and 1 (7%) was an observational retrospective study [18].…”

Section: Resultsmentioning

confidence: 99%

The impact of tumor board on breast cancer care: evidence from a systematic literature review and a meta-analysis

Pilla

Cozzolino²,

Mannocci

et al. 2022

Preprint

View full text Add to dashboard Cite

BackgroundBreast cancer is the most common malignancy in women, with a complex clinical path that involves several professionals. A multidisciplinary approach is therefore essential and there is a growing emphasis on its application to breast cancer care. However, the effectiveness of breast cancer multidisciplinary care and the processes that contribute to its effectiveness have not yet been firmly determined. This study aims to evaluate the impact of MTBs on breast cancer care outcomes.MethodsA systematic literature review was carried out through Scopus, Web of Science and Pubmed databases. The search was restricted to articles assessing the impact of MTB implementation on breast cancer care, written in English and Italian language, published between 1995 and 2021.The quality of the included articles was assessed using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies and the Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group from National Heart, Lung and Blood Institute Study Quality Assessment Tools. To combine not homogeneous results, when appropriate, meta-analysis was performed.ResultsFourteen studies, published between 2006 and 2021, were included in the review. From the quality assessment, seven studies were found to be of FAIR and seven of GOOD quality. The most analysed outcomes were: diagnosis, therapy and survival. Four out of four studies showed that with the implementation of the MTB there was a change in diagnosis, and seven out of seven studies reported changes in the treatment plan after MTB implementation. In terms of survival, results were not unanimous. A pooled analysis of three studies reporting results on the outcome “mortality” showed, in the fixed-effects model (p=0.43), a statistically significant 14% reduction of mortality relative risk for patients enrolled versus not enrolled in MTBs (pooled HR = 0.86; 95%CI: 0.81- 0.97). ConclusionsThis study shows that the implementation of the MTBs is a valuable approach to deliver appropriate and effective care to patients affected by breast cancer and to improve their outcomes. Further studies are needed to enrich the evidences available to date concerning especially the outcomes less investigated, but important to improve clinical care and care processes.

show abstract

“…Median TTT with clinics on different days was 24.4 days, similar to our median of 22 days. Comparatively, time to NAC was 12.7 days for patients attending a 1‐day multidisciplinary clinic 16 . As international rates of NAC use in breast cancer are increasing, 17–19 the increased use of multidisciplinary care clinics should be considered given the potential for a significant reduction in TTT.…”

Section: Discussionmentioning

confidence: 99%

Time to treatment and hospital visits for patients undergoing neoadjuvant chemotherapy for breast cancer in a single payer system

Guay

Cordeiro

Roberts

2022

Journal of Surgical Oncology

View full text Add to dashboard Cite

Background and Objectives Neoadjuvant chemotherapy (NAC) requires coordination of various services to ensure timely and accurate delivery of care. This can result in multiple hospital visits and extend time to treatment (TTT). The primary purpose of our study was to evaluate time to NAC for patients at a regional cancer centre. Healthcare resource use in the form of hospital visits before NAC was also evaluated. Methods A retrospective chart analysis of patients with invasive breast cancer who underwent NAC between 1 January 2012 and 31 December 2018 was performed. Results Overall, 286 patients underwent NAC. Median TTT was 22 days (range: 2–105). Median number of visits between first consultation and NAC was 5 (range: 0–12). Majority of additional visits were for diagnostic imaging/interventions, with a median number of 4 visits (range: 0–10). Each additional hospital visit increased time to NAC treatment by 14%. Conclusions Women undergoing NAC require multiple visits before initiating treatment—the majority of these visits are for diagnostic imaging. These results support the need for the coordination of multidisciplinary care and diagnostic imaging for breast cancer patients undergoing NAC to reduce hospital visits, improve the patient experience, and reduce TTT.

show abstract

The effect of 1-day multidisciplinary clinic on breast cancer treatment

Cited by 9 publications

References 23 publications

Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

The impact of tumor board on breast cancer care: evidence from a systematic literature review and a meta-analysis

Time to treatment and hospital visits for patients undergoing neoadjuvant chemotherapy for breast cancer in a single payer system

Contact Info

Product

Resources

About